Inositol is one of the cheapest things on the supplement shelf and one of the most confusingly labelled. It is sold as a single product but it is really two molecules — myo-inositol and D-chiro-inositol — blended at a ratio that most shoppers have never heard of and that most products either get wrong or refuse to disclose. The good news is that judging an inositol product is unusually tractable: there is a dose the trials actually used, a split that should be printed on the label, and a per-gram price you can calculate in your head. This guide is about how to read those three things. It is not a ranking of products we never tested, and it will not tell you inositol works better than the evidence says it does.
Criterion 1 — Which inositol is actually in the bottle
Start here, because everything else depends on it. Myo-inositol is the form that dominates food and biology; the body converts some of it to D-chiro-inositol using an insulin-dependent epimerase, and the resulting MI:DCI ratio differs from tissue to tissue.[1] They are not interchangeable grades of the same ingredient. Myo-inositol is the species the ovary appears to need, and it is the one behind the great majority of the human trials.
That asymmetry has a practical consequence that cuts against the marketing instinct that more of the “active” isomer must be better. The published rationale for the standard blend runs the other way: the “D-chiro-inositol paradox” proposes that in PCOS ovaries the epimerase is overactive, over-converting myo-inositol and leaving the follicle locally myo-inositol-deficient.[2] And feeding young adult female mice D-chiro-inositol alone at doses corresponding to roughly 1,200 mg/day in humans altered ovarian histology, raised serum testosterone and reduced ovarian aromatase.[5] That is a mouse study, not a human safety finding — but it is a good reason to be suspicious of any product selling high-dose DCI on its own as a PCOS supplement. If a label puts D-chiro-inositol first, or in hundreds of milligrams, that is a signal to look elsewhere.
Criterion 2 — The 40:1 ratio, and how strong that evidence really is
Nearly every combination product on the market uses 40 parts myo-inositol to 1 part D-chiro-inositol. The stated reason is specific and, on its face, sensible: 40:1 is meant to reproduce the reported physiological MI:DCI ratio in human plasma, and the papers laying out that rationale argue that DCI-heavy formulations are the ones that go wrong.[3] A 40:1 product at the usual dose therefore delivers about 4 g of myo-inositol and about 100 mg of D-chiro-inositol a day.
Now the part the product pages leave out. The human evidence that 40:1 specifically beats plain myo-inositol at a matched dose is very thin. The one trial that compared ratios head-to-head randomised 56 women with PCOS across seven arms — eight patients per arm— to DCI alone or to MI:DCI ratios from 1:3.5 up to 80:1 at 2 g twice daily for three months, and concluded that 40:1 performed best, with effectiveness falling off as the ratio shifted in favour of DCI.[4] Eight people per arm is a hypothesis-generating study, not a settled answer, and the ratio literature comes largely from one cluster of authors with commercial and society affiliations in the inositol field. The 2023 international PCOS guideline is unambiguous about where that leaves a shopper: no specific inositol type, dose or combination can be recommended, because the evidence is not good enough to distinguish them.[6]
So how should that change your behaviour? Not by avoiding 40:1 — it is a defensible default and it is what the trials that do exist mostly used. But by refusing to pay a premium for it, and by treating a plain myo-inositol product as a perfectly reasonable choice rather than an inferior one. What you should insist on is that both numbers are printed. A product that states “myo-inositol 2,000 mg, D-chiro-inositol 50 mg” per serving is legible. A product that says “inositol blend 2,050 mg (40:1)” is asking you to take its arithmetic on faith, and one that just says “inositol” is telling you nothing at all.
Criterion 3 — Dose: read the label in grams per day
This is where cheap products quietly fail. PCOS trials cluster tightly on 2 g of myo-inositol twice daily — about 4 g/day, usually with folic acid; the ratio-comparison trial used exactly that schedule,[4] and the gestational-diabetes prevention trials pooled by Cochrane used 2 g of myo-inositol plus 200 micrograms of folic acid twice daily.[10]Four grams a day is the number to hold in your head while you shop.
Then do the division. A 500 mg capsule means eight capsules a day to reach 4 g. A 600 mg capsule means seven. A bottle of 120 capsules at 500 mg is a fifteen-day supply at the trial dose, not a four-month supply — even though the label’s “2 capsules daily” suggested otherwise. That gap between the serving size printed on the bottle and the dose actually studied is the most common way an inositol purchase goes wrong: people buy a product, take the suggested two capsules, and are taking a quarter of the trial dose without realising it.
The same arithmetic exposes the low-dose blend capsule. A “women’s hormone complex” with 250 mg of inositol alongside a dozen other ingredients is not an inositol supplement in any meaningful sense — you would need sixteen capsules a day, and the other fifteen ingredients would come along for the ride at doses nobody has studied. If inositol is what you want, buy inositol.
Criterion 4 — Powder or capsules, and what a gram actually costs
Inositol is one of the few supplements where the format question has an easy answer. Four grams a day is a lot of material to encapsulate, and inositol happens to be a water-soluble, faintly sweet crystalline powder — it dissolves in a glass of water and tastes mildly of sugar rather than of anything medicinal. That combination makes powder the sensible default: one level scoop, stirred into water or coffee, twice a day, with no counting.
Powder also wins decisively on cost per gram, and the spread between formats is large. You are paying for encapsulation, for a bottle that holds a fraction as much active material, and often for a brand premium on top. The comparison to run before you buy is not price per bottle or price per serving but price per gram of myo-inositol: divide the total cost by the grams of myo-inositol in the container, and compare that number across candidates. Because the per-gram spread across the category is wide, this single calculation usually decides the purchase, and it frequently reveals that the “clinical strength” capsule costs several times what the plain powder does for the same daily dose.
Capsules still earn their keep in two situations: if you travel and cannot carry a tub and a scoop, or if you genuinely cannot tolerate the texture. If you go that route, buy the highest per-capsule milligram you can find so the count stays manageable, and accept that you are paying for convenience. One practical note either way: splitting the dose and taking it with food is standard, because gastrointestinal upset — nausea, gas, bloating, loose stools — is the symptom that caps the dose, and it becomes more common as the dose climbs.[11]
| What to check on the label | What good looks like | Why it matters |
|---|---|---|
| Which isomer | Myo-inositol named explicitly, in milligrams | Myo-inositol carries almost all of the human trial data; DCI is a different molecule |
| The MI:DCI split | Both amounts printed separately (commonly 40:1) | The ratio rationale is mechanistic and thinly tested — you should at least be able to see it |
| D-chiro-inositol amount | Roughly 1/40th of the myo dose, not hundreds of mg | High-dose DCI alone produced an androgenic, PCO-like picture in mice |
| Daily dose | Servings that reach ≈ 4 g/day of myo-inositol | That is the dose the PCOS and gestational-diabetes trials used |
| Format | Powder unless you have a reason to prefer capsules | 4 g/day is many capsules; inositol is soluble and mildly sweet in water |
| Price | Cost per gram of myo-inositol, not per bottle | The per-gram spread across the category is large and often decides the purchase |
| Third-party testing | Independent Certificate of Analysis with a matching lot number | Verifies identity and actual content — the guideline notes supplement quality control varies product to product |
| Marketing | No fertility, live-birth or weight-loss promises | Those outcomes are unproven; overreach signals a seller that ignores the evidence |
Criterion 5 — Third-party testing and manufacturing
Inositol is a dietary supplement, not a medicine, and the 2023 PCOS guideline says the quiet part plainly: the regulatory status, quality control and actual dosing of inositol supplements may differ from pharmaceutical products and vary product to product.[6] What is printed on a label is a claim, not a guarantee. The most useful counterweight is an independent Certificate of Analysis (COA) — outside-lab verification of identity and actual inositol content, plus screening for heavy metals and microbial contamination — carrying a batch or lot number you can match to the tub in your hand. “Lab tested” printed on the front of a bottle is not that. Prefer manufacturing in a facility following current Good Manufacturing Practices (cGMP), and a short, legible ingredient list: for a single-ingredient powder, the list really can be one line.
What to ignore
Three patterns account for most of the bad products in this category. Proprietary blends that hide the split — if the label gives one combined inositol number, you cannot tell how much myo-inositol you are getting, and the cheapest way to hit a big-sounding total is not necessarily the one you want. “PCOS complex” formulas that fold a token inositol dose into berberine, chromium, cinnamon and a proprietary herbal matrix: these are almost always underdosed on the one ingredient with the trial evidence, and they make the dose arithmetic impossible. And outcome claims the data do not support — the most common are fertility and weight loss, and both are overreach. On fertility, a Cochrane review of 13 trials in 1,472 subfertile women with PCOS concluded it is genuinely uncertain whether myo-inositol improves live birth, on low-to-very-low quality evidence.[9] On weight, the most favourable pooled analysis put the BMI difference versus placebo at −0.45 kg/m² — on the order of a couple of pounds over months, in trials designed around menstrual cycles rather than weight.[7] A bottle that promises either is telling you how it treats evidence generally.
How to choose in 60 seconds
Confirm the label names myo-inositol and states its milligrams. If it is a blend, check that the D-chiro-inositol amount is printed separately and is small — roughly a fortieth of the myo dose, not hundreds of milligrams. Work out how many servings it takes to reach about 4 g/day of myo-inositol, and how many days the container therefore lasts. Default to powder unless you have a specific reason not to. Require a third-party COA and cGMP manufacturing. Then rank your finalists on cost per gram of myo-inositol and buy the cheapest one that passed the previous steps. Reject anything promising a baby or a smaller waist.
Safety, and who should not be self-prescribing this
At PCOS-range doses inositol is unusually well tolerated — the guideline evidence review found fewer gastrointestinal adverse events on myo-inositol than on metformin, with events mild and self-limiting in both arms — and the same review found metformin may outperform inositol for hirsutism and waist-to-hip ratio, which is worth knowing before you substitute one for the other.[8] Nausea, gas, bloating and loose stools are the dose-limiting symptoms, and they become more likely as the dose rises.[11] Splitting the dose and taking it with food is the usual mitigation.
Pregnancy is the one context where none of this should be a solo decision. The gestational-diabetes prevention data are the most striking numbers in the inositol literature, but Cochrane graded them low to very low certainty, six of seven trials came from a single country, and no included trial reported perinatal mortality or a morbidity composite.[10] Dose, timing and whether to take it at all belong to the clinician managing the pregnancy. The same goes for anyone taking metformin or other prescribed medication, or being treated for subfertility.
Where inositol sits next to the alternatives
If your goal is metabolic rather than menstrual, it is worth knowing what else is on the table. Inositol is not a weight-loss drug and is in no sense a substitute for one — for what the prescription medications actually do in this population, see semaglutide for PCOS. And if you find yourself comparing supplement insulin sensitisers, our review of the berberine evidence applies the same standard we have used here: a named ingredient, a studied dose, third-party testing, and claims that match the data rather than the marketing.
The honest bottom line
There is no verified “best inositol supplement,” and any site claiming to have lab-tested and ranked exact products should make you skeptical. What there is, unusually for this shelf, is a clear specification: myo-inositol named in milligrams, any D-chiro-inositol disclosed separately and kept small, servings that reach about 4 g/day, a third-party COA, cGMP manufacturing, and the lowest cost per gram among the products that clear those bars. Powder will usually win. Buy on that specification, keep your expectations where the evidence puts them — a low-certainty case for better cycle regularity in PCOS, not a fertility treatment and not a metabolic drug — and make the decision with a clinician if you are pregnant, trying to conceive, or taking anything else.
This is a buyer’s guide, not medical advice, and nothing here is a recommendation of any specific product or brand. Inositol is sold as a dietary supplement; it is not FDA-approved to treat polycystic ovary syndrome, infertility or gestational diabetes, and it is not a substitute for prescribed treatment. Do not start inositol during pregnancy or while trying to conceive, alongside metformin or other prescribed medication, or in place of care you are already receiving, without discussing it with your own clinician.